Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
Total | Transactions | Amount |
Buys | 11 | $641,940 |
Sells | 126 | $5,108,688 |
Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
24 Oct 2022 17:13 | TRDA | Entrada Therapeutics Inc | DOWDEN NATHAN J | Chief Operating Officer | 21 Oct 2022 | Sale | 2,771 | 18.285 | 50,668 | D |
24 Oct 2022 17:10 | TRDA | Entrada Therapeutics Inc | DOSHI DIPAL | President and CEO | 21 Oct 2022 | Sale | 2,786 | 18.2759 | 50,917 | D |
23 Sep 2022 16:59 | TRDA | Entrada Therapeutics Inc | DOSHI DIPAL | President and CEO | 21 Sep 2022 | Sale | 3,402 | 15.1162 | 51,425 | D |
28 Sep 2022 17:12 | TRDA | Entrada Therapeutics Inc | DOSHI DIPAL | President and CEO | 27 Sep 2022 | Sale | 3,453 | 15.0402 | 51,934 | D |
06 Dec 2022 17:02 | TRDA | Entrada Therapeutics Inc | WENTWORTH KORY JAMES | Chief Financial Officer | 02 Dec 2022 | Sale | 2,910 | 18.1957 | 52,949 | D |
12 Jul 2023 16:32 | TRDA | Entrada Therapeutics Inc | SETHURAMAN NATARAJAN | Chief Scientific Officer | 10 Jul 2023 | Sale | 3,026 | 18.002 | 54,474 | D |
12 Jul 2023 16:33 | TRDA | Entrada Therapeutics Inc | DOWDEN NATHAN J | Chief Operating Officer | 10 Jul 2023 | Sale | 3,200 | 18.0016 | 57,605 | D |
26 Dec 2023 16:35 | TRDA | Entrada Therapeutics Inc | WENTWORTH KORY JAMES | Chief Financial Officer | 22 Dec 2023 | Sale | 3,677 | 16.4837 | 60,611 | D |
27 Oct 2022 18:48 | TRDA | Entrada Therapeutics Inc | DOWDEN NATHAN J | Chief Operating Officer | 25 Oct 2022 | Sale | 3,034 | 20.1043 | 60,996 | D |
27 Oct 2022 18:46 | TRDA | Entrada Therapeutics Inc | DOSHI DIPAL | President and CEO | 25 Oct 2022 | Sale | 3,055 | 20.009 | 61,127 | D |
27 Oct 2022 18:49 | TRDA | Entrada Therapeutics Inc | KREHER NERISSA | Chief Medical Officer | 25 Oct 2022 | Sale | 2,998 | 21.4193 | 64,215 | D |
29 Dec 2022 16:51 | TRDA | Entrada Therapeutics Inc | DOSHI DIPAL | President and CEO | 28 Dec 2022 | Sale | 4,521 | 15.0081 | 67,852 | D |
12 Jul 2023 16:34 | TRDA | Entrada Therapeutics Inc | WENTWORTH KORY JAMES | Chief Financial Officer | 11 Jul 2023 | Sale | 3,884 | 17.9979 | 69,904 | D |
03 Jan 2023 16:32 | TRDA | Entrada Therapeutics Inc | KREHER NERISSA | Chief Medical Officer | 30 Dec 2022 | Sale | 5,200 | 13.4484 | 69,932 | D |
12 Jul 2023 16:33 | TRDA | Entrada Therapeutics Inc | DOWDEN NATHAN J | Chief Operating Officer | 11 Jul 2023 | Sale | 3,897 | 18.048 | 70,333 | D |
19 Apr 2023 18:06 | TRDA | Entrada Therapeutics Inc | SETHURAMAN NATARAJAN | Chief Scientific Officer | 17 Apr 2023 | Sale | 3,961 | 18.0045 | 71,316 | D |
12 Dec 2022 16:36 | TRDA | Entrada Therapeutics Inc | WENTWORTH KORY JAMES | Chief Financial Officer | 08 Dec 2022 | Sale | 4,550 | 18.9534 | 86,238 | D |
27 Oct 2022 18:49 | TRDA | Entrada Therapeutics Inc | KREHER NERISSA | Chief Medical Officer | 26 Oct 2022 | Sale | 4,317 | 22.0108 | 95,021 | D |
04 Aug 2023 16:50 | TRDA | Entrada Therapeutics Inc | KREHER NERISSA | Chief Medical Officer | 04 Aug 2023 | Sale | 6,898 | 14.1376 | 97,521 | D |
26 Dec 2023 16:35 | TRDA | Entrada Therapeutics Inc | WENTWORTH KORY JAMES | Chief Financial Officer | 22 Dec 2023 | Sale | 6,529 | 15.2417 | 99,513 | D |
29 Jun 2022 16:02 | TRDA | Entrada Therapeutics Inc | DOWDEN NATHAN J | Chief Operating Officer | 27 Jun 2022 | Sale | 7,714 | 13 | 100,282 | D |
27 Oct 2022 18:49 | TRDA | Entrada Therapeutics Inc | KREHER NERISSA | Chief Medical Officer | 25 Oct 2022 | Sale | 4,942 | 20.5305 | 101,462 | D |
12 Jul 2023 16:34 | TRDA | Entrada Therapeutics Inc | WENTWORTH KORY JAMES | Chief Financial Officer | 10 Jul 2023 | Sale | 6,116 | 17.9788 | 109,958 | D |
23 Aug 2022 18:28 | TRDA | Entrada Therapeutics Inc | WENTWORTH KORY JAMES | Chief Financial Officer | 19 Aug 2022 | Sale | 8,529 | 13.0766 | 111,530 | D |
27 Oct 2022 18:48 | TRDA | Entrada Therapeutics Inc | DOWDEN NATHAN J | Chief Operating Officer | 25 Oct 2022 | Sale | 5,414 | 20.9689 | 113,526 | D |
22 Jun 2023 16:46 | TRDA | Entrada Therapeutics Inc | DOWDEN NATHAN J | Chief Operating Officer | 22 Jun 2023 | Sale | 7,097 | 16.0208 | 113,700 | D |
20 May 2024 17:26 | TRDA | Entrada Therapeutics Inc | SETHURAMAN NATARAJAN | Chief Scientific Officer | 17 May 2024 | Sale | 8,305 | 15.1416 | 125,751 | D |
23 Jun 2023 16:20 | TRDA | Entrada Therapeutics Inc | WENTWORTH KORY JAMES | Chief Financial Officer | 21 Jun 2023 | Sale | 8,593 | 14.8399 | 127,519 | D |
22 Jun 2023 16:46 | TRDA | Entrada Therapeutics Inc | DOWDEN NATHAN J | Chief Operating Officer | 20 Jun 2023 | Sale | 8,885 | 14.9357 | 132,704 | D |
23 Jun 2023 16:20 | TRDA | Entrada Therapeutics Inc | WENTWORTH KORY JAMES | Chief Financial Officer | 21 Jun 2023 | Sale | 8,907 | 15.1711 | 135,129 | D |
29 Dec 2022 16:51 | TRDA | Entrada Therapeutics Inc | DOSHI DIPAL | President and CEO | 27 Dec 2022 | Sale | 9,069 | 15.0384 | 136,383 | D |
04 Aug 2023 16:50 | TRDA | Entrada Therapeutics Inc | KREHER NERISSA | Chief Medical Officer | 03 Aug 2023 | Sale | 9,464 | 14.7432 | 139,530 | D |
04 Aug 2023 16:50 | TRDA | Entrada Therapeutics Inc | KREHER NERISSA | Chief Medical Officer | 02 Aug 2023 | Sale | 9,280 | 15.0876 | 140,013 | D |
20 May 2024 17:26 | TRDA | Entrada Therapeutics Inc | SETHURAMAN NATARAJAN | Chief Scientific Officer | 20 May 2024 | Sale | 9,675 | 15.188 | 146,944 | D |
27 Oct 2022 18:46 | TRDA | Entrada Therapeutics Inc | DOSHI DIPAL | President and CEO | 25 Oct 2022 | Sale | 7,506 | 20.7578 | 155,808 | D |
12 Jul 2023 16:32 | TRDA | Entrada Therapeutics Inc | SETHURAMAN NATARAJAN | Chief Scientific Officer | 11 Jul 2023 | Sale | 14,852 | 18.039 | 267,915 | D |
16 May 2024 16:33 | TRDA | Entrada Therapeutics Inc | KIM PETER S | Director | 14 May 2024 | Purchase | 25,000 | 14.5869 | 364,672 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)